geneOmbio

What geneOmbio does

geneOmbio Technologies Pvt Ltd is a Pune-based, NABL-accredited genomics services company founded in 2005 by Sachin Purohit. The firm operates a single central laboratory delivering four integrated service lines: (1) Contract Research Services covering microbial identification via 16S rRNA Sanger sequencing and whole-genome sequencing, ISO/IEC 17025-accredited DNA barcoding, and cell bank characterization for biopharma manufacturing; (2) Pharmacogenomics panels spanning fertility, psychiatry, oncology, dermatology, and cardiac support using Sanger sequencing and TaqMan genotyping; (3) Molecular Diagnostics including viral load and drug-resistance genotyping for HIV, HBV, HCV, HPV, MTB, and CMV/HSV, plus oncogenetics (KRAS, JAK2, BCR/ABL); and (4) Nutrigenomics consumer panels covering weight, diabetes, heart, and comprehensive health blueprints, distributed via the GeneSupport sub-brand with doorstep sample collection. The underlying technology stack spans automated fluorescent Sanger sequencing, robotized real-time PCR, RT-LAMP, conventional thermal cyclers, and an NGS data analytics capability added in the 2024 state-of-the-art facility expansion.

The customer base is multi-vertical and B2B-weighted: pharmaceutical and biopharma R&D teams (contract research and CRO pharmacogenomics), hospitals and diagnostic labs (24/7 hotline + cold-chain sample logistics), academic and government research institutions (Ministry of AYUSH pre-diabetes project, Symbiosis University workshops and internships), dairy farmers and A2-milk brands (CSN2 genotyping), and direct-to-consumer nutrigenomics buyers. Revenue mechanics are entirely fee-for-service and quote-based — no disclosed pricing tiers, subscription models, or recurring contracts — with sales conducted through a consultative direct B2B motion, website quote requests, and the GeneSupport consumer channel. The company is founder-controlled (Sachin Purohit), privately held with no institutional investors disclosed, and operates exclusively in India despite advisor-level ambitions in global agricultural genomics and development-finance-funded omics.

The commercial moat rests on the regulatory stack (NABL ISO/IEC 17025:2017, ISO 15189:2022, ISO 9001:2015, DSIR) and 20+ years of validated SOPs, peer-reviewed publications (40+), and database submissions to BOLD and GenBank (1,000+ barcoding projects). Leadership combines ISO-auditor-trained scientific staff (Managing Director Dr. Yashwant Chavan) with senior pharma clinical-trial experience (Medical Advisor Dr. Kedar Joshi, 50+ Phase I-IV trials), which is unusually credentialed for a sub-50-person Indian boutique CRO. The recent buildout, ISO 15189:2022 upgrade, and addition of an ag-biotech advisor with World Bank ties point to an attempt to scale into higher-value pharma contract research and AI-enabled agricultural genomics, though no revenue, funding, or cross-border traction is yet disclosed.

Name

geneOmbio

Legal name

geneOmbio Technologies Pvt Ltd

Website

https://geneombiotechnologies.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

geneOmbio is a Pune-based, NABL-accredited genomics services firm offering contract research, pharmacogenomics, molecular diagnostics, and nutrigenomics to pharma, healthcare, dairy, and consumer customers across India.

Ownership category

akta.pro rank

Product category

Genomics Contract Research and Molecular Diagnostics

NAICS

Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

akta.pro secondary industries

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)

Keywords

• Genomics contract research
• Molecular diagnostics services
• Pharmacogenomics testing
• DNA barcoding services
• Nutrigenomics testing

Headquarters

HQ city

Pune

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Contract Research Services: Fee-for-service model providing genomics research services to pharma, biopharma, food, agriculture, dairy, and life science industries. Includes microbial identification, cell bank characterization, DNA barcoding, and custom project services.
2. Pharmacogenomics Testing: Genetic testing services for personalized medicine including fertility support, psychiatry support, onco support, dermatology support, cardiac support, and clinical trial genotyping for CROs.
3. Nutrigenomics Consumer Testing: Direct-to-consumer and healthcare provider-ordered genetic testing for personalized nutrition, providing diet plans and lifestyle recommendations based on genetic profiles.
4. Molecular Diagnostics Services: Clinical diagnostic testing services for infectious diseases, drug resistance genotyping, oncogenetics, and genetic disorders. Services offered to hospitals, clinics, and healthcare providers.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

geneOmbio is a biotechnology organization delivering genomics-based contract research and molecular diagnostics services from its NABL-accredited facility in Pune, India. Core offerings include contract research services (microbial identification, DNA barcoding, cell bank characterization), pharmacogenomics testing (fertility, psychiatry, oncology, cardiac, dermatology panels), molecular diagnostics (HIV, HBV, HCV, MTB drug resistance and genotyping, oncogenetics), and nutrigenomics testing for personalized nutrition.

Product overview

geneOmbio is a biotechnology organization offering a comprehensive portfolio of genomics services across four core areas: Contract Research Services (microbial identification, DNA barcoding, cell bank characterization), Pharmacogenomics (personalized medicine testing for fertility, psychiatry, oncology, cardiology, and dermatology), Molecular Diagnostics (infectious disease testing, drug resistance genotyping, oncogenetics), and Nutrigenomics (personalized nutrition panels for health, weight, diabetes, and heart health, offered via the GeneSupport sub-brand). The company operates its own NABL-accredited laboratory with advanced instrumentation including Sanger sequencing, real-time PCR, and NGS platforms.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Research Services High-quality contract genomics services for pharma, biopharma, food, agriculture, dairy, and life science industries, including R&D project execution for private and government organizations encompassing microbial identification, DNA barcoding, and cell bank characterization.
• Microbial Identification Services Expert microbial identification using 16S rRNA Sanger sequencing and Whole Genome Sequencing (WGS) for bacteria, archaea, fungi, and algae with ≥99% accuracy, including species- and strain-level identification for research and quality control customers.
• DNA Barcoding Services ISO 17025 and NABL accredited species identification using standardized DNA markers (COI, ITS, matK, rbcL, 16S rRNA, CytB) for plants, animals, insects, and microorganisms, with submission to BOLD and GenBank databases for biodiversity conservation, food safety, pharmaceutical validation, and environmental monitoring.
• Cell Bank Characterization Services Comprehensive cell bank characterization including identity tests (16S rRNA sequencing), purity tests (bacterial/fungal impurity, bacteriophage detection), stability tests (copy number by real-time PCR), and viability tests (CFU assay, MTT assay) for biopharmaceutical manufacturing customers.
• Pharmacogenomics Testing Precision medicine testing using Sanger sequencing and TaqMan genotyping to determine optimal medication and dosage based on genetic profile across fertility, psychiatry, oncology, dermatology, and cardiac support panels, plus CRO genotyping services for clinical trials.
• Molecular Diagnostics Services Advanced molecular diagnostic testing analyzing genetic sequences in DNA, RNA, and proteins for human pathogen detection (HBV, HCV, HIV, HPV, MTB, CMV, HSV, influenza), drug resistance and genotyping, oncogenetics, and genetic disorders, offered to hospitals, clinics, and healthcare providers.
• Nutrigenomics Testing Personalized nutrition genetic testing analyzing 50+ genetic markers covering lipid metabolism, inflammation, detoxification, bone health, methylation, vitamin D metabolism, insulin sensitivity, fat storage, obesity risk, and digestive intolerances to provide diet plans and lifestyle recommendations, offered in partnership with GeneSupport.
• A1/A2 Milk Testing Service DNA-based beta-casein genotyping (CSN2 gene) using Sanger sequencing to identify A1A1, A1A2, or A2A2 cows, provided to dairy farmers for breeding selection and to brands and retailers for product differentiation and verification of 'A2' labels.

Quantifiable outcome

• ≥99% accuracy for bacterial identification using 16S rRNA sequencing
• +5 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Partnerships

Four partnerships are on record, tiered core and minor.

• GeneSupportcoreStrategic or Co-development PartnerGeneSupport is a nutrigenomics organization providing gene-based diet and exercise consultations, with a focus on prevention and management of lifestyle diseases including cardiac disease, diabetes, and weight management. geneOmbio collaborates with GeneSupport to provide comprehensive genetic testing and analysis for nutrigenomics services.
• Symbiosis International University, PunecoreStrategic or Co-development PartnergeneOmbio has organized and conducted various workshops on Nutrigenomics at Symbiosis International University. The company also provides a platform for internship for students to complete their projects in Nutrigenomics, supporting academic research and educational development in genomics.
• Kaivalyadhama (KSMYM Samiti), LonavalaminorStrategic or Co-development PartnerPartnership with Ministry of AYUSH - Govt. of India sanctioned project addressing pre-diabetic population and studying gene expression to delay onset of diabetic symptoms. GeneOmbio is associated with this research initiative for gene expression studies.
• Dairy Farmers and BrandsminorOthersgeneOmbio provides A1/A2 milk testing services to dairy farmers for breeding selection and to brands/retailers for product differentiation and verification of 'A2' labels. First NABL and ISO/IEC 17025-accredited lab in the region for Sanger sequencing-based CSN2 gene testing.

Scale indicators7 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• MapMyGenome: Indian personal genomics company offering DTC genetic testing including nutrigenomics, pharmacogenomics, and health-risk panels—direct overlap on nutrigenomics and PGx consumer testing with GeneSupport sub-brand.
• Strand Life Sciences: Indian genomics and bioinformatics company providing clinical diagnostics, molecular testing, and research services to pharma and clinicians—closely overlaps geneOmbio's contract research and diagnostics offerings.
• MedGenome: India- and US-based genomics and molecular diagnostics company offering clinical genetic testing, NIPT, oncology, and pharmacogenomics—directly comparable service portfolio, customer base (hospitals, clinicians), and NABL/CAP-accredited lab model.

Emerging players

• Xcode Life: Indian DTC personal genomics startup focused on nutrition, fitness, and wellness genetic reports—directly comparable to geneOmbio's nutrigenomics consumer panel business and GeneSupport sub-brand.
• Lilac Insights: India-based reproductive and clinical genetics testing company offering fertility, carrier, and pharmacogenomic panels—overlaps with geneOmbio's fertility PGx and reproductive medicine service line.

Broad incumbents

• Neogen Corporation: Global animal and food safety genomics company offering DNA-based species identification, microbial testing, and dairy genomics—directly comparable to geneOmbio's DNA barcoding and A1/A2 milk testing services.
• Eurofins Genomics: Global genomics services arm of Eurofins Scientific offering DNA sequencing, DNA barcoding, microbial ID, and pharmacogenomics at large scale—same service mix as geneOmbio's contract research arm but with vastly greater geographic reach and capacity.
• Dr. Lal PathLabs: India's largest diagnostic chain offering routine and specialized molecular testing (infectious disease, oncology) to hospitals and patients—competes on the molecular diagnostics side and benefits from massive national collection network.
• Metropolis Healthcare: Indian pan-India diagnostics chain with molecular and genetic testing menus—competes for hospital channel molecular diagnostics work and offers broader geographic reach.

Regional players

• Syngene International: Leading Indian CRO providing molecular biology, genomics, and bioanalytical services to global pharma—competes for the same enterprise pharma CRO contracts in India, though at materially larger scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/watch?v=RQBhkfjurLM
• Xx.com/geneOmbioTech

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about geneOmbio